Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COLIGROW
2024-513523-16-00Phase 3Completed
- Sponsor
- Hospital Universitario 12 de Octubre
- Start
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of Propess in intrauterine growth restriction (IUGR) (2 arms), sponsored by Hospital Universitario 12 de Octubre. Primary endpoint: Vaginal delivery. Started Mar 2023; status: completed.
02
Drugs
Propess
03
Conditions
intrauterine growth restriction (IUGR)
Beyond the preview
Go deeper on 2024-513523-16-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-513523-16-00.